Action item | Aim | Monitor’s actions | Comments |
---|---|---|---|
1 | Decrease the requirement for site-level monitoring; by implementing alternative monitoring mitigations | TC or email site staff (PI team) to ask if/when they are available for a TC or VC in place of an on-site monitoring visit and what data could be shared with the monitor ahead of this virtual meeting. | Use video conferencing if the site has the IT access. If not, then a TC. Ensure monitors have the flexibility to meet with site staff when it is convenient for the sites. |
2 | Prioritise patient safety, outstanding site actions and data integrity of the study primary endpoint for remote monitoring | Develop a template tracker to ensure the minimum safety and primary endpoint data are discussed in the TC/VC. | Put the questions in priority order for the TC/VC. |
3 | Give the site as much time as possible to prepare* | Request appropriate documents ahead of the meeting—keep this to a critical minimum. | This could include investigator site files (ISFs); delegation logs; primary endpoint pseudonymised source data. |
4 | Conduct a successful site TC/VC. | Review appropriate documents ahead of the meeting. | In line with preparation for all monitoring visit types |
5 | Prioritise the discussion with the site in case the call is cut short by technical problems or a local emergency. | Use the template tracker completed with all actions required of the site and prioritise the TC/VC discussion accordingly. | Discuss the timing of the next remote visit |
6 | Manage any resulting issues | Escalate any unreported SAEs, missing visits, major deviations impact on patient safety/data integrity of missing visits. | Quality, CI, PI, stats and sponsor may need to be consulted. Update study risk assessment with site-specific issues and/or availability during COVID-19 outbreak. Consider what appropriate actions, if necessary, should be undertaken |
7 | Complete the monitoring visit report (MVR) and site f/up letter. | As normal. | No comments. |